Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.91 - $1.75 $333,085 - $640,549
-366,028 Reduced 4.53%
7,711,669 $9.87 Million
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $3.88 Million - $14.2 Million
2,939,919 Added 57.22%
8,077,697 $11.1 Million
Q3 2023

Nov 14, 2023

BUY
$3.02 - $4.05 $849,997 - $1.14 Million
281,456 Added 5.8%
5,137,778 $15.6 Million
Q2 2023

Aug 14, 2023

BUY
$2.79 - $5.03 $9.52 Million - $17.2 Million
3,411,065 Added 236.02%
4,856,322 $16 Million
Q1 2023

May 15, 2023

BUY
$3.14 - $8.22 $2.31 Million - $6.05 Million
735,728 Added 103.69%
1,445,257 $4.6 Million
Q4 2022

Feb 14, 2023

BUY
$5.77 - $8.49 $694,973 - $1.02 Million
120,446 Added 20.45%
709,529 $4.91 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $7.39 $2.21 Million - $4.35 Million
589,083 New
589,083 $3.73 Million
Q1 2021

May 17, 2021

SELL
$16.59 - $33.89 $996,810 - $2.04 Million
-60,085 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$27.5 - $37.92 $955,240 - $1.32 Million
-34,736 Reduced 36.63%
60,085 $2.6 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $43.75 $383,833 - $487,593
-11,145 Reduced 10.52%
94,821 $5.12 Million
Q2 2020

Aug 14, 2020

BUY
$27.12 - $45.97 $2.87 Million - $4.87 Million
105,966 New
105,966 $6.47 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.